<?xml version='1.0' encoding='UTF-8'?><xml><records><record><source-app name="HighWire" version="7.x">Drupal-HighWire</source-app><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Vinall, Maria</style></author></authors><secondary-authors><author><style face="normal" font="default" size="100%">Alva, Maria L.</style></author></secondary-authors></contributors><titles><title><style face="normal" font="default" size="100%">Complications of Diabetes Have a Significant Long-Term Impact on QoL</style></title><secondary-title><style face="normal" font="default" size="100%">MD Conference Express</style></secondary-title></titles><dates><year><style  face="normal" font="default" size="100%">2010</style></year><pub-dates><date><style  face="normal" font="default" size="100%">2010-11-01 00:00:00</style></date></pub-dates></dates><pages><style  face="normal" font="default" size="100%">19-22</style></pages><abstract><style  face="normal" font="default" size="100%">The United Kingdom Prospective Diabetes [UKPDS] Study was a landmark randomized, multicenter trial of glycemic therapies in 5102 patients with newly diagnosed type 2 diabetes mellitus. This article discusses updated results, drawing on the UKPDS Post Trial Monitoring Study, which was conducted between 1997 and 2007.</style></abstract><number><style face="normal" font="default" size="100%">9</style></number><volume><style face="normal" font="default" size="100%">10</style></volume></record></records></xml>